Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • DOW vs GSK✓SelectedUSD · GSKDOW vs GSK performance historyLatest closeAs of-4.03%11/20
Stock and ETF performance explorer

DOW vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-35.1%
GSK return
+40.7%
Excess return
-75.7%
Maximum drawdown
-64.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-4.0%-0.1%-3.9%-4.0%
7D-12.1%-5.3%-6.8%-11.1%
30D-4.4%-3.7%-0.8%-3.8%
3M-10.7%-7.3%-3.5%-9.5%
6M-18.2%-4.2%-14.0%-17.9%
YTD+28.4%+0.9%+27.5%+25.6%
1Y+45.4%+7.3%+38.1%+39.9%
3Y-33.2%+52.7%-86.0%-42.4%
All-35.1%+40.7%-75.7%-46.2%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling